0000885590-15-000033.txt : 20150505 0000885590-15-000033.hdr.sgml : 20150505 20150505165723 ACCESSION NUMBER: 0000885590-15-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150501 FILED AS OF DATE: 20150505 DATE AS OF CHANGE: 20150505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stolz Brian M. CENTRAL INDEX KEY: 0001524803 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 15833804 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST CITY: LAVAL STATE: A8 ZIP: H7L 4A8 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-05-01 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001524803 Stolz Brian M. 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 QUEBEC, CANADA 0 1 0 0 EVP, Administration & CHCO Common Stock, no par value 2015-05-01 4 M 0 3675 A 96060 D Common Stock, no par value 2015-05-01 4 F 0 1921 0 D 94139 D Restricted Share Units 2015-05-01 4 M 0 3675 0 D Common Stock 3675 0 D Each performance-based Restricted Share Unit ("PSU") represents a contingent right to receive between zero and three common shares, no par value ("Common Shares"), of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (2). This represents the number of units vested on the PSUs that were previously reported on the original Form 4. The initial grant was reported to vest based on total shareholder return ("TSR") between a price of $43.50 starting on December 7, 2011 and the average stock price for the 20 trading days starting on each measurement dates: 25% on September 7, 2014, 50% on December 7, 2014 and 25% on March 7, 2015. Unit vesting is contingent on TSR performance between 15% and 45% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels. These performance-based RSUs have now vested in full. This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based RSUs. by: Nicholas Zanoni for Brian Stolz 2015-05-05